Browsing Over 131 Presentations

Sort By
Preclinical studies to identify effective combination therapies Educational session

Live Q&A and discussion (ID 21)

Lecture Time
17:00 - 17:15
Speakers
  • Philippe Bedard (Toronto, Ontario, Canada)
Session Name
Preclinical studies to identify effective combination therapies
Room
Channel 1
Date
Mon, 01.03.2021
Time
16:00 - 17:15
Authors
  • Philippe Bedard (Toronto, Ontario, Canada)
  • Patricia Lorusso (New Haven, CT, United States of America)
  • Bissan Al-Lazikani (Sutton, United Kingdom)
  • Emile Voest (Amsterdam, Netherlands)
  • Rene Bernards (Amsterdam, Netherlands)
  • Nicola Valeri (Sutton, United Kingdom)
Microbiome: Moving beyond immunotherapy Educational session

Assessing the microbiome: Tools for analysis and value as predictive factor to immunotherapy (ID 27)

Lecture Time
13:00 - 13:15
Speakers
  • Thomas F. Gajewski (Chicago, IL, United States of America)
Session Name
Microbiome: Moving beyond immunotherapy
Room
Channel 1
Date
Tue, 02.03.2021
Time
13:00 - 14:15
Authors
  • Thomas F. Gajewski (Chicago, IL, United States of America)
Microbiome: Moving beyond immunotherapy Educational session

Pharmacology and lessons from non-cancer research (ID 28)

Lecture Time
13:15 - 13:30
Speakers
  • Maria Rescigno (Milan, Italy)
Session Name
Microbiome: Moving beyond immunotherapy
Room
Channel 1
Date
Tue, 02.03.2021
Time
13:00 - 14:15
Authors
  • Maria Rescigno (Milan, Italy)
Microbiome: Moving beyond immunotherapy Educational session

Patient selection for early phase clinical trials: How akkermansia muciniphila can become a diagnostic tool and a therapeutic strategy (ID 29)

Lecture Time
13:30 - 13:45
Speakers
  • Lisa Derosa (Villejuif, France)
Session Name
Microbiome: Moving beyond immunotherapy
Room
Channel 1
Date
Tue, 02.03.2021
Time
13:00 - 14:15
Authors
  • Lisa Derosa (Villejuif, France)
Microbiome: Moving beyond immunotherapy Educational session

Bugs as drugs: Using the microbiome to augment immunotherapy responses (ID 30)

Lecture Time
13:45 - 14:00
Speakers
  • Lillian Siu (Toronto, ON, Canada)
Session Name
Microbiome: Moving beyond immunotherapy
Room
Channel 1
Date
Tue, 02.03.2021
Time
13:00 - 14:15
Authors
  • Lillian Siu (Toronto, ON, Canada)
Microbiome: Moving beyond immunotherapy Educational session

Live Q&A and discussion (ID 31)

Lecture Time
14:00 - 14:15
Speakers
  • Lillian L. Siu (Toronto, ON, Canada)
Session Name
Microbiome: Moving beyond immunotherapy
Room
Channel 1
Date
Tue, 02.03.2021
Time
13:00 - 14:15
Authors
  • Lillian L. Siu (Toronto, ON, Canada)
  • E.G. Elisabeth De Vries (Groningen, AL, Netherlands)
  • Thomas F. Gajewski (Chicago, IL, United States of America)
  • Maria Rescigno (Milan, Italy)
  • Lisa Derosa (Villejuif, France)
Antibody-drug conjugate (ADC) technology Educational session

Clinical development of next generation ADCs (ID 35)

Lecture Time
14:30 - 14:45
Speakers
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
Session Name
Antibody-drug conjugate (ADC) technology
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
Antibody-drug conjugate (ADC) technology Educational session

Re-positioning the payload (ID 36)

Lecture Time
14:45 - 15:00
Speakers
  • Noboru Yamamoto (Chuo-ku, Japan)
Session Name
Antibody-drug conjugate (ADC) technology
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Noboru Yamamoto (Chuo-ku, Japan)
Antibody-drug conjugate (ADC) technology Educational session

ADCs and new targets in solid tumours (ID 37)

Lecture Time
15:00 - 15:15
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Session Name
Antibody-drug conjugate (ADC) technology
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Giuseppe Curigliano (Milan, Italy)
Antibody-drug conjugate (ADC) technology Educational session

Tumour-targeted immune-stimulating antibody conjugates (ISACs): A new class of immuno-oncology therapeutics (ID 38)

Lecture Time
15:15 - 15:30
Speakers
  • Shelley Ackerman (Redwood City, CA, United States of America)
Session Name
Antibody-drug conjugate (ADC) technology
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Shelley Ackerman (Redwood City, CA, United States of America)
Antibody-drug conjugate (ADC) technology Educational session

Live Q&A and discussion (ID 39)

Lecture Time
15:30 - 15:45
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Session Name
Antibody-drug conjugate (ADC) technology
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Giuseppe Curigliano (Milan, Italy)
  • Noboru Yamamoto (Chuo-ku, Japan)
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
  • Shelley Ackerman (Redwood City, CA, United States of America)
Where next with oncolytics? Educational session

Viro-immunotherapy and RNA-based oncolytic virotherapy (ID 40)

Lecture Time
16:00 - 16:15
Speakers
  • Alex A. Adjei (Rochester, NY, United States of America)
Session Name
Where next with oncolytics?
Room
Channel 2
Date
Mon, 01.03.2021
Time
16:00 - 17:15
Authors
  • Alex A. Adjei (Rochester, NY, United States of America)